Literature DB >> 12360280

Deregulated homeobox gene expression in cancer: cause or consequence?

Cory Abate-Shen1.   

Abstract

Homeobox genes comprise a large and essential family of developmental regulators that are vital for all aspects of growth and differentiation. Although many studies have reported their deregulated expression in cancer, few studies have established direct functional roles for homeobox genes in carcinogenesis. Nonetheless, most cases of deregulated homeobox gene expression in cancer conform to a simple rule: those that are normally expressed in undifferentiated cells are upregulated in cancer, whereas those that are normally expressed in differentiated tissues are downregulated in cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12360280     DOI: 10.1038/nrc907

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  237 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Integrative epigenomic and genomic analysis of malignant pheochromocytoma.

Authors:  Johanna Sandgren; Robin Andersson; Alvaro Rada-Iglesias; Stefan Enroth; Goran Akerstrom; Jan P Dumanski; Jan Komorowski; Gunnar Westin; Claes Wadelius
Journal:  Exp Mol Med       Date:  2010-07-31       Impact factor: 8.718

Review 3.  Role of homeobox genes in normal mammary gland development and breast tumorigenesis.

Authors:  Hexin Chen; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

4.  Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression.

Authors:  Davide Gabellini; Ivan N Colaluca; Hartmut C Vodermaier; Giuseppe Biamonti; Mauro Giacca; Arturo Falaschi; Silvano Riva; Fiorenzo A Peverali
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

5.  Growth arrest-specific homeobox is associated with poor survival in patients with hepatocellular carcinoma.

Authors:  Peng Zhou; Zhi Chen; Rui-Min Chang; Wei Jiang; Lie-Lin Wu; Zhi-Ming Wang
Journal:  Med Oncol       Date:  2012-05-27       Impact factor: 3.064

6.  Msx2 induces epithelial-mesenchymal transition in mouse mammary epithelial cells through upregulation of Cripto-1.

Authors:  M G di Bari; E Ginsburg; J Plant; L Strizzi; D S Salomon; B K Vonderhaar
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

7.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

Review 8.  Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Authors:  Ricardo D Coletta; Paul Jedlicka; Arthur Gutierrez-Hartmann; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

9.  Dual functions of the homeoprotein DLX4 in modulating responsiveness of tumor cells to topoisomerase II-targeting drugs.

Authors:  Bon Q Trinh; Song Yi Ko; Nicolas Barengo; Shiaw-Yih Lin; Honami Naora
Journal:  Cancer Res       Date:  2012-12-07       Impact factor: 12.701

10.  The Sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways.

Authors:  Carlos S Moreno
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.